证券记录 · 已归档季度
BRKR
Bruker Corporation · Healthcare · Medical - Devices
19被追踪持有人
0Δ持有人
49.38M持有股份
$1.60B报告持仓市值
+3新建仓位
−4清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +4.5% · 净新建仓位 -5.3% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 38.48K | $1.97M | n/a | n/a |
| Q2 2026 | 119 | +10 | 81.03M | $4.87B | +18 | −7 |
| Q1 2026 | 111 | -2 | 77.83M | $2.81B | +8 | −11 |
| Q4 2025 | 114 | +1 | 81.30M | $3.83B | +4 | −2 |
| Q3 2025 | 19 | 0 | 49.38M | $1.60B | +3 | −4 |
| Q2 2025 | 17 | +3 | 44.89M | $1.85B | +4 | −1 |
| Q1 2025 | 11 | 0 | 11.41M | $475.20M | +3 | −3 |
| Q4 2024 | 11 | -2 | 10.42M | $610.89M | +1 | −3 |
| Q3 2024 | 12 | -1 | 5.68M | $392.44M | n/a | −1 |
| Q2 2024 | 13 | n/a | 8.60M | $549.04M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.73M | +63.4% | $446.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 10.96M | -1.1% | $356.00M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 3 | The Vanguard Group ✦ (被动) | 10.40M | -0.3% | $338.03M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (被动) | 3.74M | -1.2% | $121.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 2.19M | n/a | $71.01M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 6 | Geode Capital Management ✦ (被动) | 2.09M | +1.3% | $67.76M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 1.32M | -51.5% | $42.74M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 8 | Point72 Asset Management ✦ | 1.06M | 新增 | $34.49M | 0.1% | New | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 847.36K | +65.6% | $27.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 624.96K | n/a | $20.30M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | JPMorgan Chase ✦ | 613.07K | n/a | $19.92M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 12 | Millennium Management ✦ | 570.27K | +470.4% | $18.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Glenview Capital ✦ | 319.67K | 新增 | $10.39M | 0.3% | New | 1 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 258.82K | -54.0% | $8.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 205.92K | 新增 | $6.69M | 0.0% | New | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 200.00K | -33.0% | $6.50M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 139.61K | -20.6% | $4.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 77.25K | +4.3% | $2.51M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 36.01K | -98.9% | $1.12M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $34.49M | 0.1% |
| Glenview Capital | $10.39M | 0.3% |
| D. E. Shaw & Co. | $6.69M | 0.0% |
已清仓
| Norges Bank | $44.46M | 曾为 0.0% |
| Scion Asset Management | $10.30M | 曾为 18.3% |
| Arrowstreet Capital | $1.38M | 曾为 0.0% |
| Marshall Wace | $251,814 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 339 持有人, 136.43M 股份, $4.78B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 15
Munch Mark
Officer · 2.00K 股 · $105,740
Aug 17
Pusch Wolfgang
Officer · 3.47K 股 · $197,614
Aug 14
Munch Mark
Officer · 2.00K 股 · $115,200
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据